A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy
- PMID: 30979055
- PMCID: PMC6518224
- DOI: 10.3390/jcm8040494
A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy
Abstract
Recent studies have shown that body composition is an important factor that affects surgical site infection (SSI). However, each study has utilized different body composition criteria. Therefore, in this study, we aim to determine the most predictable body composition criteria for the prediction of SSI after gastrectomy. The visceral fat area (VFA), subcutaneous fat area (SFA), and muscle area were assessed by a preoperative-stage computed tomographic (CT) scan. To compare the predictive performance of body composition for SSI, logistic regression models were used, and the models were compared using the receiver operation characteristic (ROC) curve and the area under the curve (AUC) value. Of the 1038 eligible patients, 58 patients (5.6%) developed SSI. The VFA-to-SFA ratio showed the best predictive performance (mean AUC 75.11). The cutoff value for the SSI of the VFA-to-SFA ratio was 0.94, and the sensitivity and specificity were 67.86% and 77.65%, respectively. A multivariate logistic analysis indicated that a total gastrectomy (OR, 2.13; p = 0.017), stage III or IV cancer (OR, 2.66; p = 0.003), and a high VFA-to-SFA ratio (OR, 8.09; p < 0.001) were independent risk factors for SSI after gastrectomy. The VFA-to-SFA ratio is the most predictable body composition model for use in predicting the incidence of SSI after gastrectomy.
Keywords: body composition; gastrectomy; gastric cancer; outcomes; risk factors; surgical site infection; visceral-to-subcutaneous fat ratio.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Fitzmaurice C., Allen C., Barber R.M., Barregard L., Bhutta Z.A., Brenner H., Dicker D.J., Chimed-Orchir O., Dandona R., Dandona L., et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–548. - PMC - PubMed
-
- Sano T., Sasako M., Yamamoto S., Nashimoto A., Kurita A., Hiratsuka M., Tsujinaka T., Kinoshita T., Arai K., Yamamura Y., et al. Gastric cancer surgery: Morbidity and mortality results from a prospective randomized controlled trial comparing d2 and extended para-aortic lymphadenectomy—Japan clinical oncology group study 9501. J. Clin. Oncol. 2004;22:2767–2773. doi: 10.1200/JCO.2004.10.184. - DOI - PubMed
LinkOut - more resources
Full Text Sources
